A dermatologist evaluation is essential
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
We gladly offer certificates of analysis on request
Cardiovasc Drugs Ther (2013) 27(2):1338
Nausea Diarrhea Abdominal pain Vomiting Constipation Headache Fatigue Dizziness Low blood sugar The time it takes to see results with Semaglutide in weight loss can vary from person to person